2,794
Views
13
CrossRef citations to date
0
Altmetric
Review Article

Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice

, &
Pages 246-253 | Received 03 Nov 2016, Accepted 15 Aug 2017, Published online: 16 Oct 2017

References

  • Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837–847.
  • Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. J Am Med Assoc. 2001;285:2370–2375.
  • Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125.
  • Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–1678.
  • Mittal S. Differentiating paroxysmal from persistent atrial fibrillation: long-term electrocardiographic monitoring is mightier than. The Clinician. J Am Coll Cardiol. 2014;63:2849–2851.
  • Friberg L, Rosenqvist M, Lindgren A, et al. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke. 2014;45:2599–2605.
  • Jørgensen HS, Nakayama H, Reith J, et al. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke. 1996;27:1765–1769.
  • Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996;27:1760–1764.
  • Youman P, Wilson K, Harraf F, et al. The economic burden of stroke in the United Kingdom. Pharmacoeconomics. 2003;21(Suppl 1):43–50.
  • National Institute for Health and Care Excellence. Atrial fibrillation: management. Clinical guideline [CG180] [Internet]. [updated August 2014]. Available from: https://www.nice.org.uk/guidance/cg180
  • January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1–e76.
  • Hobbs FDR, Taylor CJ, Jan Geersing G, et al. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care. Eur J Prev Cardiolog. 2016;23:460–473.
  • Martinez C, Katholing A, Wallenhorst C, et al. Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013. Heart. 2015;101:1748–1754.
  • Kishore A, Vail A, Majid A, et al. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke. 2014;45:520–526.
  • Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120–129.
  • Binici Z, Intzilakis T, Nielsen OW, et al. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation. 2010;121:1904–1911.
  • Siontis KC, Gersh BJ, Killian JM, et al. Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm. 2016;13:1418–1424.
  • Lowres N, Neubeck L, Redfern J, et al. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost. 2013;110:213–222.
  • Fitzmaurice DA, Hobbs FDR, Jowett S, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. Br Med J. 2007;335:383.
  • Hobbs FDR, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005;9:1–74.
  • Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111:1167–1176.
  • Kaasenbrood F, Hollander M, Rutten FH, et al. Yield of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device during influenza vaccination. Europace. 2016;18:1514–1520.
  • Jacobs MS, Kaasenbrood F, Postma MJ, et al. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands. Europace. 2016;euw285. DOI:10.1093/europace/euw285
  • Kearley K, Selwood M, Van den BA, et al. Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open. 2014;4:e004565.
  • Svennberg E, Engdahl J, Al Khalili F, et al. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation. 2015;131:2176–2184.
  • Aronsson M, Svennberg E, Rosenqvist M, et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace. 2015;17:1023–1029.
  • Camm AJ, Lip GYH, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719–2747.
  • Lip GYH, Ramsay SG. Insights from the RCPE UK consensus conference on approaching the comprehensive management of atrial fibrillation. Expert Rev Cardiovasc Ther. 2012;10:697–700.
  • Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;50:e1–e88.
  • National Institute for Health and Care Excellence. Atrial fibrillation: management. Clinical guideline [CG180]: evidence. [Internet]; 2014. Available from: https://www.nice.org.uk/guidance/cg180/evidence
  • National Screening Committee. Screening for atrial fibrillation in the over 65s. [Internet]; 2014. Available from: http://legacy.screening.nhs.uk/policydb_download.php?doc=447
  • Kakkar AK, Mueller I, Bassand JP, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD Registry. PLoS One. 2013;8:e63479.
  • Martinez C, Cohen AT, Bamber L, et al. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemost. 2014;112:255–263.
  • Freedman SB, Lowres N. Asymptomatic atrial fibrillation: the case for screening to prevent stroke. J Am Med Assoc. 2015;314:1911–1912.
  • Fitzmaurice DA, McCahon D, Baker J, et al. Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study. Fam Pract. 2014;31:298–302.
  • Wilson JMG, Jungner G, Principles and practice of screening for disease. Geneva: World Health Organization; 1968. (Public Health Papers, No 34). [Internet]; Available from: http://apps.who.int/iris/handle/10665/37650
  • Chan PH, Poh YC, Pun L, et al. Diagnostic performance of a smartphone-based photoplethysmographic application for atrial fibrillation screening in a primary care setting. J Am Heart Assoc. 2016;5:e003428.
  • Freedman SB. Screening for atrial fibrillation using a smartphone: is there an app for that? J Am Heart Assoc. 2016;5:e004000.
  • Orchard J, Freedman SB, Lowres N, et al. iPhone ECG screening by practice nurses and receptionists for atrial fibrillation in general practice: the GP-SEARCH qualitative pilot study. Aust Fam Physician. 2014;43:315–319.
  • Orchard J, Lowres N, Freedman SB, et al. Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): a feasibility study. Eur J Prev Cardiolog. 2016;23(2 suppl):13–20.
  • Taggar JS, Coleman T, Lewis S, et al. Screening for atrial fibrillation-A cross-sectional survey of healthcare professionals in primary care. PLoS One. 2016;11:e0152086.
  • Verberk WJ, Omboni S, Kollias A, et al. Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations. Int J Cardiol. 2016;203:465–473.
  • National Institute for Health and Care Excellence. WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension. Medical technology guidance [MTG13]. [Internet]; 2013. Available from: https://www.nice.org.uk/guidance/mtg13
  • Tieleman RG, Plantinga Y, Rinkes D, et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace. 2014;16:1291–1295.
  • Vaes B, Stalpaert S, Tavernier K, et al. The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care. BMC Fam Pract. 2014;15:113.
  • Doliwa PS, Rosenqvist M, Frykman V. Paroxysmal atrial fibrillation with silent episodes: intermittent versus continuous monitoring. Scand Cardiovasc J. 2012;46:144–148.
  • Lau JK, Lowres N, Neubeck L, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol. 2013;165:193–194.
  • Haberman ZC, Jahn RT, Bose R, et al. Wireless smartphone ECG enables large-scale screening in diverse populations. J Cardiovasc Electrophysiol. 2015;26:520–526.